GlassScriptPhysician profile
Chinh Duc Nguyen
NPI 1265553986
$543.39
in general payments reported to CMS, 2019-2025
10 companies · $185 in 2025
The $185 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21.32 · 2021: $12.62 · 2022: $139 · 2023: $24.13 · 2024: $161 · 2025: $185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $370.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $370.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $263.71 | 2022-2025 | Ortholoc 2 Lapifuse, Pangea, Dart-Fire |
| Smith+Nephew, INC. | $50.61 | 2024 | Grafix Pl, Collagenase Santyl |
| Depuy Synthes Sales INC. | $36.07 | 2025 | Na |
| Reprise Biomedical, INC. | $35.11 | 2024-2025 | Miro3d, Mirodry |
| Horizon Therapeutics Plc | $33.94 | 2019-2021 | |
| Amgen INC. | $30.13 | 2024-2025 | Krystexxa |
| Tactile Systems Technology INC | $28.04 | 2022-2024 | Flexitouch Plus, Entre Plus |
| Abbott Laboratories | $24.13 | 2023 | Proclaim |
| Stimlabs LLC | $23.83 | 2025 | Corplex P |
| Vertex Pharmaceuticals Incorporated | $17.82 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chinh Nguyen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.